ALPCO launches panel of 13 stool-based gastroenterology assays: 4 points

ALPCO launched a new panel of 13 stool-based gastroenterology assays.

Here are four points:

1. The panel of 13 assays consists of various biomarkers to aid in the investigation of IBD, exocrine pancreatic function, food intolerance and colorectal cancer.

2. The assays are all compatible with one single extraction step.

3. The extraction method allows laboratories to improve their sample processing time by extracting one sample for up to 13 biomarkers.

4. Additionally, each of these assays is flexible and can be run manually or on automated open platforms.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast